Clinical Trials Directory

Trials / Completed

CompletedNCT04378907

Assessing Electronic Cigarette Nicotine Flux

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Virginia Commonwealth University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine differences in nicotine delivery, use behavior, carbon monoxide delivery, subjective effects, and physiological effects, when cigarette smokers use an electronic cigarette with constant device settings and different e-liquid concentrations.

Detailed description

Only one arm enrolled.

Conditions

Interventions

TypeNameDescription
OTHERCigarette Smoker/ECIG users: 0 mg/ml nicotine concentrationECIG LAB SESSION: 30 watts, 0 mg/ml nicotine concentration. During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.
OTHERCigarette Smokers/ECIG users: 6 mg/ml nicotine concentrationECIG Lab Session, 30 watts, 6 mg/ml nicotine concentration. During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.
OTHERCigarette Smokers/ECIG users: 15 mg/ml nicotine concentrationECIG Lab Session, 30 watts, 15 mg/ml nicotine concentration. During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.
OTHERCigarette Smokers/ECIG users: 30 mg/ml nicotine concentrationECIG Lab Session, 30 watts, 30 mg/ml nicotine concentration During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.

Timeline

Start date
2021-01-05
Primary completion
2023-02-01
Completion
2023-02-01
First posted
2020-05-07
Last updated
2026-02-04
Results posted
2026-02-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04378907. Inclusion in this directory is not an endorsement.